News & Announcements

Leadership in research and innovation paired with an ever-evolving course of study keeps pace with diverse and dynamic careers in pharmacy and beyond.

Despite being preventable and curable, tuberculosis remains the world’s leading infectious disease killer. According to the World Health Organization, an estimated 10.6 million people became ill with tuberculosis and 1.3 million died from the disease in 2022 alone.

The Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium has been awarded a $30.8M grant over five years to research the most effective treatment options for future clinical testing.

A former Navy helicopter pilot, now a VA pain management clinical pharmacist, draws on military and personal experiences to deliver exceptional, patient-centered care.

Diana Cowell, PharmD, MBA, leveraged her military and pharmacy experience from around the world to provide comprehensive medication management and become a specialist in pain management for veterans. 

The first in person even since 2019. Join the School of Pharmacy’s annual Spring Research Seminar, showcasing faculty, staff, and student posters. 

School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.

The 2024 Innovations in Regulatory Science Summit at UCSF-Stanford CERSI brought together FDA leaders, industry, and academia to discuss public health, regulatory challenges, and innovation.

The fifth annual summit was UCSF-Stanford CERSI’s largest in-person meeting yet, showcasing the School’s commitment to the dynamic field of regulatory science in discussions with FDA center directors and past and present FDA commissioners.

A leader in computational biology and integrative structure modeling, Andrej Sali, PhD, was selected by the UCSF Academic Senate to give the Annual Faculty Research Lectureship in Basic Science.

Attend in person at Mission Bay or on Zoom at 3:30 p.m. Pacific on Tuesday, April 16. Reception to follow.

The 2024 Bowes Biomedical Investigator has been named, set to explore new scientific directions such as the intersection of GPCR research and neuropsychiatric diseases.

The GPCR and neuropsychiatric diseases researcher will receive $1.25 million over five years to explore new territory.

Channeling his passion for chemistry and computers into the ever-evolving landscape of pharmacy, Hearns has carved out his own lane.

The first program of its kind in the United States, the MS in AICD3 will enable its graduates to gain a competitive edge for some of the most desirable jobs in the biopharmaceutical industry and in academia.

UCSF’s Industry Documents Library leads students to publish the first studies of problematic opioid industry practices.

Linda Cheng and Siavash Panahi earn first-place honors in the American Society of Health-System Pharmacists (ASHP) 28th Clinical Skills Competition.

The recognition of Krogan, Shoichet, Manglik, and Giacomini underscores the School’s commitment to fostering groundbreaking research that addresses critical issues in health care and pharmaceutical sciences.

An emeritus faculty member and UCSF Medal winner who pushed the field of pharmaceutical chemistry into the computational era passed away after his 90th birthday.

A tribute is planned for January 13, 2024, in honor of the clinical pharmacy pioneer who became a role model for social justice, education, and service in the field of pharmacy.

The award from the American Society of Health-System Pharmacists and the Association of Black Health-System Pharmacists recognizes efforts to reduce racial and ethnic disparities in health care.